Why Studios?

The studio model offers a more focused and capital-efficient approach to company creation. Studios don’t just fund startups—they design and build them from the ground up. By combining the technology, capital, and personnel needed to efficiently advance multiple programs in parallel.

The model has a strong track record of success in both tech and biotech, and it is inherently flexible:

• Some studios focus on early discovery and validation.

• Others accelerate translational development or drive late-stage clinical execution.

• All can be purpose-built to suit a specific strategy or mission.

Why Sponsors Choose Studios

For universities, research institutions, and strategic investors, studios offer a de-risked and scalable path to turning innovation into impact.

Key advantages include:

• Outsourced diligence and decision-making
  Studios absorb the cost, time, and complexity of evaluating opportunities, assembling leadership, and managing execution.  The Studio also brings a broader set of skills than is traditionally present at academic institutions.

• Integrated company-building
  Studios bring together complementary technologies from various sources, as well as a diverse set of capabilities and relationships to give each new company the unique tools it needs to succeed.

• Leverage of human capital
  A small, senior team can support multiple projects in parallel, extending scarce expertise across a broader pipeline and enabling company formation even in regions with limited biotech infrastructure.  This is particularly important in areas where life science talent is scarce.

The Miletus Approach

Miletus engages with studios in two ways:

• As Advisors, we help institutions, funds, and investors design and launch studio platforms tailored to their goals.

• As Operators, we co-found and run our studios—sourcing science, building teams, and driving execution across the biotech lifecycle.